Cargando…

One-year implant survival following lateral window sinus augmentation using plasma rich in growth factors (PRGF): a retrospective study

BACKGROUND: The aim of this study was to assess one-year implant survival after lateral window sinus augmentation using PRGF combined with various bone grafting materials. MATERIAL AND METHODS: This was a retrospective chart review and radiographic analysis of patients that had undergone lateral win...

Descripción completa

Detalles Bibliográficos
Autores principales: Dragonas, Panagiotis, Foote, Marlon, Yu, Qingzhao, Palaiologou, Archontia, Maney, Pooja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medicina Oral S.L. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338070/
https://www.ncbi.nlm.nih.gov/pubmed/32142503
http://dx.doi.org/10.4317/medoral.23482
_version_ 1783554602720821248
author Dragonas, Panagiotis
Foote, Marlon
Yu, Qingzhao
Palaiologou, Archontia
Maney, Pooja
author_facet Dragonas, Panagiotis
Foote, Marlon
Yu, Qingzhao
Palaiologou, Archontia
Maney, Pooja
author_sort Dragonas, Panagiotis
collection PubMed
description BACKGROUND: The aim of this study was to assess one-year implant survival after lateral window sinus augmentation using PRGF combined with various bone grafting materials. MATERIAL AND METHODS: This was a retrospective chart review and radiographic analysis of patients that had undergone lateral window sinus augmentation with PRGF and had dental implants placed at least 6 months post augmentation. All implants included were followed up for at least one year after placement. Demographic, sinus and implant related characteristics (residual ridge height, sinus membrane perforation, type of graft material, implant length and width and ISQ at placement) were analyzed. RESULTS: A total of 31 patients with 39 sinus augmentations and 48 implants were included. The mean follow up was 22.8 ± 9.9 months. Implant survival was 95.8%, with 2 implants overall failing. Among all the variables assessed, the only one found to be associated with an increased risk for implant failure was the use of xenograft as bone grafting material in the sinus. CONCLUSIONS: Within the limitations of this study, dental implants placed in maxillary sinuses grafted with PRGF in combination with bone grafting materials, exhibit high implant survival rates after at least one year follow up. Key words:PRGF, sinus graft, growth factors, implant survival, platelet concentrates.
format Online
Article
Text
id pubmed-7338070
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Medicina Oral S.L.
record_format MEDLINE/PubMed
spelling pubmed-73380702020-07-13 One-year implant survival following lateral window sinus augmentation using plasma rich in growth factors (PRGF): a retrospective study Dragonas, Panagiotis Foote, Marlon Yu, Qingzhao Palaiologou, Archontia Maney, Pooja Med Oral Patol Oral Cir Bucal Research BACKGROUND: The aim of this study was to assess one-year implant survival after lateral window sinus augmentation using PRGF combined with various bone grafting materials. MATERIAL AND METHODS: This was a retrospective chart review and radiographic analysis of patients that had undergone lateral window sinus augmentation with PRGF and had dental implants placed at least 6 months post augmentation. All implants included were followed up for at least one year after placement. Demographic, sinus and implant related characteristics (residual ridge height, sinus membrane perforation, type of graft material, implant length and width and ISQ at placement) were analyzed. RESULTS: A total of 31 patients with 39 sinus augmentations and 48 implants were included. The mean follow up was 22.8 ± 9.9 months. Implant survival was 95.8%, with 2 implants overall failing. Among all the variables assessed, the only one found to be associated with an increased risk for implant failure was the use of xenograft as bone grafting material in the sinus. CONCLUSIONS: Within the limitations of this study, dental implants placed in maxillary sinuses grafted with PRGF in combination with bone grafting materials, exhibit high implant survival rates after at least one year follow up. Key words:PRGF, sinus graft, growth factors, implant survival, platelet concentrates. Medicina Oral S.L. 2020-07 2020-03-06 /pmc/articles/PMC7338070/ /pubmed/32142503 http://dx.doi.org/10.4317/medoral.23482 Text en Copyright: © 2020 Medicina Oral S.L. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Dragonas, Panagiotis
Foote, Marlon
Yu, Qingzhao
Palaiologou, Archontia
Maney, Pooja
One-year implant survival following lateral window sinus augmentation using plasma rich in growth factors (PRGF): a retrospective study
title One-year implant survival following lateral window sinus augmentation using plasma rich in growth factors (PRGF): a retrospective study
title_full One-year implant survival following lateral window sinus augmentation using plasma rich in growth factors (PRGF): a retrospective study
title_fullStr One-year implant survival following lateral window sinus augmentation using plasma rich in growth factors (PRGF): a retrospective study
title_full_unstemmed One-year implant survival following lateral window sinus augmentation using plasma rich in growth factors (PRGF): a retrospective study
title_short One-year implant survival following lateral window sinus augmentation using plasma rich in growth factors (PRGF): a retrospective study
title_sort one-year implant survival following lateral window sinus augmentation using plasma rich in growth factors (prgf): a retrospective study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338070/
https://www.ncbi.nlm.nih.gov/pubmed/32142503
http://dx.doi.org/10.4317/medoral.23482
work_keys_str_mv AT dragonaspanagiotis oneyearimplantsurvivalfollowinglateralwindowsinusaugmentationusingplasmarichingrowthfactorsprgfaretrospectivestudy
AT footemarlon oneyearimplantsurvivalfollowinglateralwindowsinusaugmentationusingplasmarichingrowthfactorsprgfaretrospectivestudy
AT yuqingzhao oneyearimplantsurvivalfollowinglateralwindowsinusaugmentationusingplasmarichingrowthfactorsprgfaretrospectivestudy
AT palaiologouarchontia oneyearimplantsurvivalfollowinglateralwindowsinusaugmentationusingplasmarichingrowthfactorsprgfaretrospectivestudy
AT maneypooja oneyearimplantsurvivalfollowinglateralwindowsinusaugmentationusingplasmarichingrowthfactorsprgfaretrospectivestudy